Nicole Karam

Nicole Karam

Interventional cardiologist / Cardiologist
Clemenceau Medical Centre - Beirut, Lebanon

Latest contributions

All about PCR’s Teaching Assessment Board (TAB)

03 Dec 2025

Learn how session feedback is compiled to create a virtuous cycle of continuous refinement for education in #interventionalcardiology

Tricuspid repair or replacement - Matching the patient to the procedural strategy

17 Nov 2025 – From PCR London Valves 2025

This session addresses the nuanced decision-making process in selecting appropriate transcatheter tricuspid repair or replacement strategies. It covers the current device landscape, patient selection criteria based on anatomical and clinical factors, and discusses emerging challenges such as pacing lead management, anticoagulation, and outcome definitions.

Tricuspid repair or replacement - Matching the patient to the procedural strategy

Early Career Research Award Final

17 Nov 2025 – From PCR London Valves 2025

Highlighting pioneering research in structural heart interventions, this session presents studies on the impact of transcatheter tricuspid valve replacement (TTVR) on left ventricular geometry and function, myocardial remodeling in aortic stenosis, physiological responses after mitral and tricuspid edge-to-edge repairs, advancing the understanding of device effects on...

Mitral TEER - LIVE Case

16 Nov 2025 – From PCR London Valves 2025

Watch this live case followed by a recorded case, regarding a 75-year-old male with type 2 DM, permanent AF, and severe LV dysfunction (30%), with a history of RCA PCI one month earlier and three hospitalizations for heart failure, presented with severe secondary mitral and tricuspid...

Mitral TEER - LIVE Case

Mitral regurgitation: from guidelines to clinical practice

16 Nov 2025 – From PCR London Valves 2025

This LIVE case symposium brings mitral regurgitation guidelines into real clinical practice. Through step-by-step patient demonstrations and insightful discussion, the session explores how recommendations guide decision-making in ventricular and atrial secondary MR, how the heart team tailors therapy to individual anatomy and comorbidities, and how device iterations...

Mitral regurgitation: from guidelines to clinical practice

Valvular interventions: are we entering the new age?

22 Sep 2025

Discover what D. Milasinovic and N. Karam shared on the practice of valvular interventions.

Innovation to address unmet clinical needs in transcatheter valve therapies

22 May 2025 – From EuroPCR 2025

Discover innovations addressing unmet clinical needs in transcatheter valve therapies. This session shares case-based experiences including young aortic stenosis patients, mitral regurgitation with annular calcification, and severe tricuspid regurgitation with right ventricular dysfunction, alongside the latest advances in TAVI, TMVR, and tricuspid interventions.

Innovation to address unmet clinical needs in transcatheter valve therapies

How to build a tricuspid programme?

20 May 2025 – From EuroPCR 2025

Learn how to build a successful tricuspid valve programme with a focus on patient screening protocols, heart team roles, and post-procedural management. Gain expert perspectives on organizational requirements, referral optimization, multidisciplinary collaboration, and quality assessment for tricuspid interventions.

How to build a tricuspid programme?

How to deal with secondary mitral regurgitation in 2025?

20 May 2025 – From EuroPCR 2025

Delve into the evolving management of secondary mitral regurgitation, and the critical role of the Heart Team. This session replay presents the latest clinical trials, treatment guidelines, and a case-based discussion covering medical and interventional strategies, heart failure optimization, frailty assessment, and advanced imaging techniques.

How to deal with secondary mitral regurgitation in 2025?

What is new in atrioventricular valves?

19 May 2025 – From EuroPCR 2025

Discover the latest advancements in atrioventricular valve interventions, including innovative transcatheter repair technologies and first-in-human experiences with novel devices.

What is new in atrioventricular valves?

Focus on Fundamentals in TAVI and mitral - PCR London Valves 2024

Christopher Cook interviews Nicole Karam about the Fundamentals Course, a key component of the PCR London Valves programme that continues to expand each year. Designed for beginners in TAVI or mitral interventions, the course guides participants through every step of a procedure, starting with the basics...

Focus on Fundamentals in TAVI and mitral - PCR London Valves 2024

New technology for transcather valve replacement - LIVE case

25 Nov 2024 – From PCR London Valves 2024

Watch a series of recorded cases showcasing advanced valve therapies and innovative techniques:

  • A 70-year-old man with Marfan syndrome (treated by Bentall and CABG in 2012), impaired LV function (35%), CRT-D, and symptomatic severe primary MR (A2 prolapse with calcification) underwent implantation of an Intrepid valve under...
New technology for transcather valve replacement - LIVE Case

Tricuspid transcatheter edge-to-edge repair - The fundamentals

25 Nov 2024 – From PCR London Valves 2024

Ready to dive into tricuspid transcatheter edge-to-edge repair (TEER)? This video breaks down the procedure by exploring real-world cases and key techniques.

Through practical case presentations, you'll gain insights into the anatomical criteria that determine suitability for TEER, the importance of imaging and haemodynamic assessments and the...

Tricuspid transcatheter edge-to-edge repair - The fundamentals

Focus on PCR Innovators Day

18 Jun 2024 – From EuroPCR 2024

Nicole Karam and Nicolo Piazza highlighted EuroPCR 2024's PCR Innovators Day, which gathered over 400 physicians, ventures, industry partners, and investors to exchange ideas and network. Key topics included valve disease, heart failure, denervation, and the obstacles to innovation across different geographies, addressed in the innovator...

Focus on PCR Innovators Day

Edge-to-edge repair for primary mitral regurgitation: the good, the bad and the ugly

16 May 2024 – From EuroPCR 2024

Discover how to select suitable patients for TEER of primary mitral regurgitation, tackle anatomical challenges, understand the technique's limits, and gain insights into managing complexities and identifying cases where TEER may not be ideal.

Edge-to-edge repair for primary mitral regurgitation: the good, the bad and the ugly

Planning for a lifetime starts with choosing the right valve first: from first TAVI to redo-TAVI

15 May 2024 – From EuroPCR 2024

Watch this session to learn the best practices for treating aortic stenosis, with a focus on lifetime management. Gain insights into evaluating patient anatomy and clinical presentation to anticipate the need for a second valve, understand different valve designs and their initial selection, and observe a...

Planning for a lifetime starts with choosing the right valve first: from first TAVI to redo-TAVI

Feedback from Innovator's Exchange Hub

13 May 2024 – From EuroPCR 2024

Feedback from Innovator's Exchange Hub

Innovations in heart failure: moving the heart forward

13 May 2024 – From EuroPCR 2024

Innovations in heart failure: moving the heart forward

Feedback from Innovator's Exchange Hub

13 May 2024 – From EuroPCR 2024

Feedback from Innovator's Exchange Hub

Innovations in transcatheter valve interventions: moving the flow in the right direction

13 May 2024 – From EuroPCR 2024

Innovations in transcatheter valve interventions: moving the flow in the right direction

How to identify patients for tricuspid interventions

14 Dec 2023

Watch the replay of this webinar with J. Hausleiter, P. Lüdike, M. Adamo, N. Karam and N. Wunderlich to know more about the clinical presentation and medical therapy of patients with tricuspid regurgitation and much more!

Challenges in TAVIs, are there guideline recommendations?

20 Nov 2023 – From PCR London Valves 2023

The EAPCI consensus session emphasized the critical role of evaluating and managing coronary artery disease in TAVI candidates, especially in younger and lower-risk patients. Transcatheter heart valve choice influences future coronary access, emphasizing the need for optimized implantation techniques. In cardiogenic shock due to valvular heart...

Challenges in TAVIs, are there guideline recommendations?

Tricuspid valve intervention in complex scenarios - Tackling tricuspid regurgitation using a multidisciplinary approach

20 Nov 2023 – From PCR London Valves 2023

This session explores the diverse phenotypes of tricuspid regurgitation patients, emphasizing the clinical implications and advocating for a multidisciplinary approach to assessment and treatment. It covers TR clinical courses, investigation pathways, and case scenarios, including atrial fibrillation, heart failure (preserved and reduced ejection fraction), pulmonary hypertension,...

Tricuspid valve intervention in complex scenarios - Tackling tricuspid regurgitation using a multidisciplinary approach

How to treat my patient with combined aortic and mitral valve disease

20 Nov 2023 – From PCR London Valves 2023

Explore this session to gain insights into diverse treatment options for combined heart valve disease. Examine the distinctions between surgical and transcatheter approaches, understanding their nuances, the sequential order of treatment and technical considerations crucial for transcatheter interventions.

How to treat my patient with combined aortic and mitral valve disease

Is only fixing functional mitral regurgitation in heart failure patients enough?

20 Nov 2023 – From PCR London Valves 2023

This session offers insights into combo therapy involving Carillon for patients with functional mitral regurgitation. It covers details of the EMPOWER trial, a double-blinded, sham-controlled study, and explores the potential benefits of early treatment for patients with functional mitral regurgitation.

Is only fixing functional mitral regurgitation in heart failure patients enough?

Key questions in tricuspid valve intervention - How do I define treatment options according to individual patient anatomy?

19 Nov 2023 – From PCR London Valves 2023

Explore this tricuspid valve-focused session featuring analysis of four clinical cases: Ebstein anomaly, severe and torrential tricuspid regurgitations, and anterior flail-related torrential regurgitation. Gain insights into optimal treatment selection for each scenario, leveraging pre-procedural imaging for informed decision-making.

Key questions in tricuspid valve intervention - How do I define treatment options according to individual patient anatomy?

Tricuspid Late-Breaking Trials: TRISCEND at 2 years, TEER in primary tricuspid regurgitation, TriCLASP, bRIGHT...

19 Nov 2023 – From PCR London Valves 2023

Discover the tricuspid late-breaking trials which were presented during PCR London Valves 2023: 

  • TRISCEND study two-year outcomes: transfemoral TTVR
  • Transcatheter edge-to-edge repair in patients with primary tricuspid regurgitation
  • One-year outcomes of transcatheter tricuspid valve repair from the TriCLASP study
  • TTVR with the LuX-Valve system: one-year outcomes of a multicentre experience
  • Real-world...
Tricuspid Late-Breaking Trials

Key questions in tricuspid valve intervention - How does the role of the right heart and pulmonary vasculature influence patient selection?

19 Nov 2023 – From PCR London Valves 2023

Explore insights from an 86-year-old female patient's case with TAVR since end-2022 who presented with permanent AF, moderate MR and TR regurgitation, and learn more about right heart catheterisation for patient selection, CT and CMR in tricuspid interventions, criteria for atrial secondary TR, and more!

How does the role of the right heart and pulmonary vasculature influence patient selection?

Implications of TRILUMINATE, a randomized clinical trial of transcatheter repair for tricuspid regurgitation

17 May 2023 – From EuroPCR 2023

Listen to Nicole Karam and Fabien Praz talk about the latest update from the TRILUMINATE study, the very first randomized trial conducted to determine how to improve the prognosis of tricuspid regurgitation.

To do so, the study aimed at comparing optimal medical treatment with interventions with edge-to-edge repair.

The content...

Implications of TRILUMINATE, a randomized clinical trial of transcatheter repair for tricuspid regurgitation

Emerging indications for TAVI

18 May 2023 – From EuroPCR 2023

Consult this session if you want to learn about emergent indications of transcatheter treatment of aortic valve disease, to appreciate current gaps in the evidence base and hear about upcoming clinical trials, and to highlight new technologies that will address these treatment gaps.

Emerging indications for TAVI